… , resulting in adverse short- and long-term outcomes[Citation52]. … -analysis of the SMART-DATE
and the DAPT-STEMI trials showed that in patients with either STEMI or NSTE-ACS, a …

… by long-term single antiplatelet therapy for the prevention of … patients undergoing PCI for a
STEMI, enoxaparin therapy was … Two randomized, controlled studies compared DES and BMS …

… is to evaluate the long-term (17 years) clinical outcome after radioactive stent … DES are
recommended over BMS in non-ST-segment elevation acute coronary syndromes (NSTE-ACS).…

… determinant of acute and long-term outcomes with the range … and aspirin in NSTE-ACS9
both before and after PCI, even though … Nevertheless, real world evidence52 showing recurrent …

… than clopidogrel in NSTE-ACS and no significant difference in major … undergoing PCI,
the pre-treatment plus long-term … bare metal stent (BMS) as well as a drug eluting stent (DES) …

… by results from trials comparing BMS versus DES in such … In fact, the recent 2020 ESC
NSTE-ACS guidelines now explicitly … Real world insights on the initiation and treatment duration of …

… The study population is to be followed up for 3 years after the index PCI. There … compared
with the prasugrel groups, we did a multivariate Cox proportional hazards regression analysis. …

… STEMI within 12 hr after symptom onset or within 12–24 hr with ongoing chest pain, ST-segment
elevation or new left bundle branch block, and NSTE-ACS within 72 hr after … stent(BMS) …

… of first-generation drug-eluting stent compared with Western … [34] After PCI, short- versus
long-term DAPT strategy significantly … DAG reports institutional grants from Bayer and BMS, and …

… (STEMI) and non-ST-segment elevation ACS (NSTE-ACS). … those in the real world, and
extending the results to patients … derived from studies comparing long-term outcomes of PCI …